Skip to main content

S&P 500 —

Nasdaq-100 —

Dow —

Nasdaq · Common stock

Freenome (FRNM)

$12.72 −$0.05 (−0.39%)

Day’s range
$12.50–$13.11
Volume
370,918

FRNM price history

FRNM closed at $12.72 on Oct. 26, 2026. Over the past year, its daily close ranged from $9.99 on July 30, 2026 to $17.11 on Sept. 18, 2026.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $8 to $18, not from zero.
Data table: FRNM daily closes, the past year
FRNM daily closing prices, July 21, 2026 to Oct. 26, 2026, newest first
DateClose
Oct. 26, 2026$12.72
Oct. 23, 2026$12.77
Oct. 22, 2026$13.10
Oct. 21, 2026$14.01
Oct. 20, 2026$14.06
Oct. 19, 2026$12.57
Oct. 16, 2026$11.75
Oct. 15, 2026$12.29
Oct. 14, 2026$12.19
Oct. 13, 2026$12.64
Oct. 12, 2026$13.22
Oct. 9, 2026$15.78
Oct. 8, 2026$15.81
Oct. 7, 2026$16.03
Oct. 6, 2026$16.36
Oct. 5, 2026$16.83
Oct. 2, 2026$16.32
Oct. 1, 2026$15.64
Sept. 30, 2026$15.75
Sept. 29, 2026$15.92
Sept. 28, 2026$16.19
Sept. 25, 2026$15.99
Sept. 24, 2026$16.01
Sept. 23, 2026$15.70
Sept. 22, 2026$16.45
Sept. 21, 2026$16.60
Sept. 18, 2026$17.11
Sept. 17, 2026$16.29
Sept. 16, 2026$14.73
Sept. 15, 2026$14.64
Sept. 14, 2026$14.96
Sept. 11, 2026$14.37
Sept. 10, 2026$14.79
Sept. 9, 2026$15.75
Sept. 8, 2026$15.99
Sept. 4, 2026$16.31
Sept. 3, 2026$16.90
Sept. 2, 2026$15.95
Sept. 1, 2026$15.25
Aug. 31, 2026$14.79
Aug. 28, 2026$14.79
Aug. 27, 2026$13.94
Aug. 26, 2026$14.09
Aug. 25, 2026$13.99
Aug. 24, 2026$13.78
Aug. 21, 2026$13.81
Aug. 20, 2026$13.51
Aug. 19, 2026$13.63
Aug. 18, 2026$13.45
Aug. 17, 2026$13.00
Aug. 14, 2026$11.56
Aug. 13, 2026$11.61
Aug. 12, 2026$11.55
Aug. 11, 2026$12.00
Aug. 10, 2026$11.62
Aug. 7, 2026$11.15
Aug. 6, 2026$10.91
Aug. 5, 2026$10.91
Aug. 4, 2026$10.91
Aug. 3, 2026$11.01
July 31, 2026$11.15
July 30, 2026$9.99
July 29, 2026$10.06
July 28, 2026$10.77
July 27, 2026$11.38
July 24, 2026$11.24
July 23, 2026$12.20
July 22, 2026$13.14
July 21, 2026$13.01

Key figures

Average daily volume
852,812Past 3 months
Market value
$1.37B
Dividend yield
—

Price change

1 month
−20.45%
3 months
+13.17%

What Wall Street says about FRNM

In the past 90 days, Wall Street firms published 5 rating or price-target actions on FRNM: 5 new ratings.

Rating and price-target actions on FRNM, past 90 days
ActionRating
GuggenheimInitiates coverageBuy$21
TD CowenInitiates coverageBuy$17
BTIGInitiates coverageBuy$17
JefferiesInitiates coverageBuy$17
Leerink PartnersInitiates coverageOutperform$18

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About Freenome, Inc. Common stock

Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.

Headquarters
New York, N.Y.
Listed
July 21, 2026
Sector
Health care
Industry
Services-medical laboratories

freenome.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about FRNM is on the site yet.

  • NTRANatera, Inc. Common Stock
  • DGXQuest Diagnostics Inc.
  • LHLabcorp Holdings Inc.
  • GHGuardant Health, Inc. Common Stock
  • CAICaris Life Sciences, Inc. Common Stock
  • GRALGRAIL, Inc. Common Stock